Morgan Stanley (MS) 13D/13G Filings for Benitec Biopharma Inc. (BNTC)

Morgan Stanley 13D and 13G filings for Benitec Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-04-12
4:57 pm
Sale		 2021-03-31 13G Benitec Biopharma Inc.
BNTC		 MORGAN STANLEY
MS		 4,984
1.800%		 -9,673decrease
(-66.00%)		 Filing
2021-03-22
4:36 pm
Purchase		 2021-03-10 13G Benitec Biopharma Inc.
BNTC		 MORGAN STANLEY
MS		 14,657
5.200%		 14,657increase
(New Position)		 Filing